Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lilith Tatham is active.

Publication


Featured researches published by Lilith Tatham.


Epidemiology | 1997

Family history and risk of fatal prostate cancer.

Carmen Rodriguez; Eugenia E. Calle; Heidi L. Miracle-McMahill; Lilith Tatham; Phyllis A. Wingo; Michael J. Thun; Clark W. Heath

To examine the relation between fatal prostate cancer and family history of prostate cancer in a first‐degree relative, we analyzed data from a prospective mortality study of 481,011 men with no history of cancer at enrollment in 1982. During 9 years of follow‐up, 1,922 deaths from prostate cancer occurred. Results from Cox proportional hazard models showed that family history of prostate cancer was related to fatal prostate cancer [rate ratio (RR) = 1.60; 95% confidence interval (CI) = 1.31–1.97]; men with two or more affected relatives had a greater than threefold increase in risk (RR = 3.19; 95% CI = 1.51–6.71). Men whose relatives were diagnosed with prostate cancer before age 65 years (RR = 2.03; 95% CI = 1.33–3.09) had a greater effect of family history than men whose relatives were diagnosed at older ages (RR = 1.50; 95% CI = 1.17–1.91). Rate ratios did not increase with decreasing age of the study participants. The 60% increase in risk for men with at least one affected relative is lower than that reported in previous studies.


Epidemiology | 1997

Occupational risk factors for subgroups of non-Hodgkin's lymphoma

Lilith Tatham; Paige E. Tolbert; Carl R. Kjeldsberg

The non‐Hodgkins lymphomas (NHL) are a diverse group of neoplasms of the lymphatic system whose incidence has been increasing in recent years. The Centers for Disease Control Selected Cancers Study, a population‐based case‐control study of several cancers, included a large number of cases of NHL and a pathology review, providing a rare opportunity to study risk factors for groups of NHL subtypes. We examined the relation between occupational exposures and three subgroups of NHL: small cell diffuse lymphomas (N = 185), follicular lymphomas (N = 268), and large cell diffuse lymphomas (N = 526). There were 1,659 controls available for comparison. After controlling for demographic variables and previously identified risk factors for NHL, we observed two interesting associations, one between solvent exposure and small cell diffuse lymphomas [odds ratio (OR) = 1.60; 95% confidence interval (CI) = 1.10–2.20], and the other between meat packaging/processing and follicular lymphomas (OR = 1.60; 95% CI = 0.99–2.60). The results of this exploratory analysis are primarily negative. Our lack of positive findings may indicate that the subgroups of NHL used may not be etiologically distinct and that further work needs to be done to develop an NHL classification system that is etiologically informative and useful for epidemiologic studies.


Epidemiology | 1998

Family history of breast cancer as a predictor for fatal prostate cancer.

Carmen Rodriguez; Eugenia E. Calle; Lilith Tatham; Phyllis A. Wingo; Heidi L. Miracle-McMahill; Michael J. Thun; Clark W. Heath

To examine the relation between family history of breast cancer in a mother or sister and a mans risk of fatal prostate cancer, we analyzed data from a prospective mortality study of adult men in the United States. During 12 years of follow-up, there were 3,141 deaths from prostate cancer in a cohort of 480,802 men who were cancer-free at study entry in 1982. Results from Cox proportional hazards models, adjusted for other risk factors, showed a modest increased risk of fatal prostate cancer associated with a family history of breast cancer(in the absence of a family history of prostate cancer) [rate ratio (RR) = 1.16; 95% confidence interval (CI) = 1.01–1.33]. The association was stronger among men younger than 65 years of age whose relatives were diagnosed with breast cancer before age 50 years (RR = 1.65; 95% CI = 0.88–3.10) and among Jewish men (RR = 1.73; 95% CI = 1.00–2.97). The increased risks observed in these subgroups may reflect genetic alterations underlying familial clustering of prostate and breast cancer. (Epidemiology 1998;9:525–529)


Clinical Infectious Diseases | 2017

Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

Carmen S. Arriola; Shikha Garg; Evan J. Anderson; Patrician A Ryan; Andrea George; Shelley M. Zansky; Nancy M. Bennett; Arthur Reingold; Marisa Bargsten; Lisa Miller; Kimberly Yousey-Hindes; Lilith Tatham; Susan Bohm; Ruth Lynfield; Ann Thomas; Mary Lou Lindegren; William Schaffner; Alicia M. Fry; Sandra S. Chaves

Background We investigated the effect of influenza vaccination on disease severity in adults hospitalized with laboratory-confirmed influenza during 2013-14, a season in which vaccine viruses were antigenically similar to those circulating. Methods We analyzed data from the 2013-14 influenza season and used propensity score matching to account for the probability of vaccination within age strata (18-49, 50-64, and ≥65 years). Death, intensive care unit (ICU) admission, and hospital and ICU lengths of stay (LOS) were outcome measures for severity. Multivariable logistic regression and competing risk models were used to compare disease severity between vaccinated and unvaccinated patients, adjusting for timing of antiviral treatment and time from illness onset to hospitalization. Results Influenza vaccination was associated with a reduction in the odds of in-hospital death among patients aged 18-49 years (adjusted odds ratios [aOR] = 0.21; 95% confidence interval [CI], 0.05 to 0.97), 50-64 years (aOR = 0.48; 95% CI, 0.24 to 0.97), and ≥65 years (aOR = 0.39; 95% CI, 0.17 to 0.66). Vaccination also reduced ICU admission among patients aged 18-49 years (aOR = 0.63; 95% CI, 0.42 to 0.93) and ≥65 years (aOR = 0.63; 95% CI, 0.48 to 0.81), and shortened ICU LOS among those 50-64 years (adjusted relative hazards [aRH] = 1.36; 95% CI, 1.06 to 1.74) and ≥65 years (aRH = 1.34; 95% CI, 1.06 to 1.73), and hospital LOS among 50-64 years (aRH = 1.13; 95% CI, 1.02 to 1.26) and ≥65 years (aRH = 1.24; 95% CI, 1.13 to 1.37). Conclusions Influenza vaccination during 2013-14 influenza season attenuated adverse outcome among adults that were hospitalized with laboratory-confirmed influenza.


American Journal of Epidemiology | 2018

Impact of Public Health Responses During a Measles Outbreak in an Amish Community in Ohio: Modeling the Dynamics of Transmission

Paul A. Gastañaduy; Sebastian Funk; Prabasaj Paul; Lilith Tatham; Nicholas Fisher; Jeremy Budd; Brian Fowler; Sietske de Fijter; Mary DiOrio; Gregory S. Wallace; Bryan T. Grenfell

We quantified measles transmissibility during a measles outbreak in Ohio in 2014 to evaluate the impact of public health responses. Case incidence and the serial interval (time between symptom onset in primary cases and secondary cases) were used to assess trends in the effective reproduction number R (the average number of secondary cases generated per case). A mathematical model was parameterized using early R values to determine the size and duration of the outbreak that would have occurred if containment measures had not been initiated, as well as the impact of vaccination. As containment started, we found a 4-fold decline in R (from approximately 4 to 1) over the course of 2 weeks and maintenance of R < 1 as control measures continued. Under a conservative scenario, the model estimated 8,472 cases (90% confidence interval (CI): 8,447, 8,489) over 195 days (90% CI: 179, 223) without control efforts and 715 cases (90% CI: 103, 1,338) over 128 days (90% CI: 117, 139) when vaccination was included; 7,757 fewer cases (90% CI: 7,130, 8,365) and 67 fewer outbreak days (90% CI: 48, 98) were attributed to vaccination. Vaccination may not account entirely for transmission reductions, suggesting that changes in community behavior (social distancing) and other control efforts (isolation, quarantining) are important. Our findings highlight the benefits of measles outbreak response and of understanding behavior change dynamics.


JAMA | 1998

Increased cancer mortality following a history of nonmelanoma skin cancer.

Henry S. Kahn; Lilith Tatham; Alpa V. Patel; Michael J. Thun; Clark W. Heath


American Journal of Epidemiology | 1997

Smoking and Fatal Prostate Cancer in a Large Cohort of Adult Men

Carmen Rodnguez; Lilith Tatham; Michael J. Thun; Eugenia E. Calle; Clark W. Heath


American Journal of Epidemiology | 2001

Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women

Carmen Rodriguez; Eugenia E. Calle; Alpa V. Patel; Lilith Tatham; Eric J. Jacobs; Michael J. Thun


The New England Journal of Medicine | 2016

A Measles Outbreak in an Underimmunized Amish Community in Ohio

Paul A. Gastañaduy; Jeremy Budd; Nicholas Fisher; Susan B. Redd; Jackie Fletcher; Julie M. Miller; Dwight J. McFadden; Jennifer S. Rota; Paul A. Rota; Carole J. Hickman; Brian Fowler; Lilith Tatham; Gregory S. Wallace; Sietske de Fijter; Amy Parker Fiebelkorn; Mary DiOrio


Open Forum Infectious Diseases | 2016

Hospital-Acquired Influenza Among Hospitalized Patients, 2011-2015

Charisse Nitura Cummings; Shikha Garg; Eileen Katherine Nenninger; Pam Daily Kirley; Nisha Alden; Kimberly Yousey-Hindes; Evan J. Anderson; Maya Monroe; Seth Eckel; Ruth Lynfield; Marisa Bargsten; Shelley M. Zansky; Nancy M. Bennett; Lilith Tatham; Ann Thomas; Mary Lou Lindegren; Gregg M. Reed; Monica Schroeder; Alicia M. Fry

Collaboration


Dive into the Lilith Tatham's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Clark W. Heath

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alicia M. Fry

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ann Thomas

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marisa Bargsten

New Mexico Department of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge